Dr. Jaemook Choi brings over 26+ years of comprehensive expertise in R&D, commercialization, and organizational operations to his role as Vice President of Operations at siRNAgen Therapeutics. His deep experience in preclinical and clinical drug development
make him invaluable in driving assets into and through the clinic. Since joining, he successfully navigated the flagship asset, SRN-001, into Phase I study in Australia. With a decade in quality management and 15 years in non-clinical studies and regulatory affairs, Dr. Choi leads early-phase development efforts in the Korea R&D site.